期刊
CANCER LETTERS
卷 520, 期 -, 页码 68-79出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2021.07.002
关键词
Cancer therapy; Cellular senescence; SASP; Senotherapy; Senolysis
类别
资金
- National Natural Science Foundation of China [81972300, 81502554]
- Natural Science Foundation Project of Chongqing [cstc2019jcyj-msxmX0669]
Cellular senescence is a stress response that can have detrimental effects during cancer therapy, including promoting tumorigenesis and therapeutic resistance. Selective removal of senescent cells is considered a promising adjuvant approach to eliminate these adverse effects.
Cellular senescence is a stress response that imposes a growth arrest on cancer and nonmalignant cells during cancer therapy. By secreting a plethora of proinflammatory factors collectively termed the senescence-associated secretory phenotype (SASP), therapy-induced senescent cells can promote tumorigenesis. Moreover, the SASP from senescent cells is also able to drive therapy resistance and mediate many adverse effects of cancer therapy. Because senescent cell production often occurs during cancer therapy, it is important to carefully consider these potential detrimental effects. Senotherapy, which refers to selective removal of senescent cells, has been proposed as a promising adjuvant approach to eliminate the adverse effects of senescent cells. Thus, in this review we summarize in detail the mechanisms by which senescent cells contribute to tumorigenesis and therapeutic resistance. Also, we thoroughly discuss the potential strategies regarding how to effectively circumvent the undesirable effects of therapy-induced senescent cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据